Navigation Links
PhRMA Elects Four New Members to Board of Directors
Date:12/21/2010

WASHINGTON, Dec. 21, 2010 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced the election of four new members to its Board of Directors.

"We are pleased to welcome four new biopharmaceutical heavyweights to join PhRMA's Board of Directors," said PhRMA President and Chief Executive Officer John J. Castellani.  "As leaders of one of the most research-intensive sectors in the U.S., they bring to the table incredible insight and a keen understanding of the challenging economic, legislative and regulatory environments the industry faces on a daily basis."  

Castellani continued, "Despite these challenges, our Board of Directors has made it a top priority to build upon core patient-centered principles that guide our advocacy efforts as we work to advance public policies that foster medical innovation and help the U.S. maintain its global leadership in medical discovery.  We look forward to working with all our Board members to this aim in the months and years ahead."  

Ian Read was recently named President and Chief Executive Officer of Pfizer Inc.  Previously, he served as Senior Vice President, Pfizer Inc., and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010.  In that role, he oversaw five global business units – Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets.  

Mr. Read began his career with Pfizer in 1978 as an operational auditor.  He held various positions, including Chief Financial Officer, Pfizer Mexico in Pfizer's Latin America operations.  In 1996, Mr. Read was appointed President of Pfizer's International Pharmaceuticals Groups, with responsibility for Latin America and Canada.  He became Executive Vice President, Europe in 2000, was named a Corporate Vice President in 2001, and assumed responsibility for Canada, in addition t
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PhRMA Statement on Senate Finance Committee Vote
2. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
3. Seven New Biopharmaceutical Research Companies Join PhRMAs Mission to Advance Medical Innovation
4. PhRMA Honors Patient Advocates Ron and Raychel Bartek
5. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
6. PhRMA Statement on Health Care Reform
7. PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy
8. PhRMA Statement on Department of Homeland Security Efforts to Crack Down on Counterfeiting Crimes
9. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
10. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
11. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , September 2, 2015 ... market for global clinical trials review of H2, ... scenario with an objective to enhance decision making ... Complete report on Keratoconus market clinical trials ... companies, 10 institutes / government organizations and supported ...
(Date:9/1/2015)... Mass. , Sept. 1, 2015  Shareholder rights ... whether certain officers and directors of ConforMIS, Inc. (NASDAQGS: ... ConforMIS is a medical technology company that uses its ... joint replacement implants that are individually sized and shaped ... this press release on the law firm,s Shareholder Rights ...
(Date:9/1/2015)... , Sept. 1, 2015 On August 31, ... Jr. , issued a 123-page order in the first ... Medical Conserve metal-on-metal hip replacement devices are defective.[1]  ... judgment as to Plaintiff Robyn Christiansen,s claims for defective ... Court flatly rejected Wright Medical,s claim that the Medical ...
Breaking Medicine Technology:Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 2Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 3Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 4Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 5Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3
... LONDON, April 21, 2012 Medaxial, the ... won a Queen,s Award for Enterprise in recognition of ... for Enterprise are the UK,s most prestigious business accolade, ... select number of companies who have achieved outstanding results ...
... INC. (Nasdaq: PDEX ) announced today that ... of Chief Executive Officer, effective immediately.  The Company also ... positions with the Company and its subsidiaries, including his ... a member of the Company,s Board of Directors, effective ...
Cached Medicine Technology:Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 2Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 3Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer 2Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer 3
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in ... from everyday life changes can lead to very serious, life-altering events. Fortunately nature ... with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses of ...
(Date:9/1/2015)... , ... September 01, 2015 , ... From Aug. 17-21, ... and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community ... 65 adult counselors, some of whom work for Calvary, and two junior counselors who ...
(Date:9/1/2015)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) has once again ... 50 Report that recognizes companies that provide the best career opportunities for Hispanic women ... number 24 to 21 of the 50 Best Companies for Latinas. The LATINA Style ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... and prevent different malignancies. Some options for cancer treatment are available belonging ... which distinctive approach is necessary for effective treatment. Several molecules have been ...
Breaking Medicine News(10 mins):Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... Alzheimer,s disease that previously showed troubling side effects may ... The keys to the safety of the drug, ... it to patients with ApoE4, a gene mutation linked ...
... in the Fallopian tubes that carry eggs from a woman,s ... but this finding goes a long way towards explaining why ... pregnant," says Sean Ward, professor of physiology and cell biology, ... the study. Ward,s study was recently published ...
... A new drug targeting the PI3K gene in patients ... early phase I investigational study conducted at Virginia G. ... by oncologist Dr. Daniel D. Von Hoff at the ... Oncology (ASCO). The drug under investigation, GDC-0941, manufactured ...
... Beth Israel Deaconess Medical Center (BIDMC) has been awarded ... Infectious Diseases (NIAID), part of the National Institutes of ... in Nonhuman Primates. The five-year grant totals $36 million. ... MD, PhD, a Professor of Medicine at Harvard Medical ...
... WEDNESDAY, July 20 (HealthDay News) -- The meteorological monster -- ... throttled much of the United States from the Southwest to ... ushering in oppressive humidity, temperatures in the high 90s and ... wave, blamed for as many as 13 deaths in the ...
... with a serious genetic blood disorder are not getting the ... to sickness. Research funded by the Economic and ... of York and Loughborough University reveals that most children with ... in catching up on absences from class. Sickle ...
Cached Medicine News:Health News:Experimental Drug Might Help Fight Alzheimer's After All 2Health News:Experimental Drug Might Help Fight Alzheimer's After All 3Health News:Nevada School of Medicine researcher finds caffeine consumption, female infertility link 2Health News:TGen, Virginia G. Piper Cancer Center studying new breast cancer drug 2Health News:'Heat Dome' Continues to Throttle U.S. 2Health News:'Heat Dome' Continues to Throttle U.S. 3Health News:Schools failing pupils with sickle cell disease 2
The First Check Home Drug Test is the first over-the counter, FDA approved home drug test that provides immediate information about the possible use of prescription drugs....
PediaVision LLC is a life sciences company dedicated to solving the critical problem of undiagnosed vision problems affecting children worldwide....
... the treatment of presbyopia, a condition that affects ... patients. , Presbyopia results from the gradual loss ... eye as a person ages, making the lens ... eye has a harder time focusing on objects ...
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
Medicine Products: